Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of 18.36% is 127% above its 5-year average of 8.08%, near the high end of its 5-year range (-342.24%–65.28%).
3.39% below its 12-month average of 19.00%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-28): 17.86%.
NET PROFIT MARGIN
18.36%
NET PROFIT MARGIN AVG TTM
19.00%
NET PROFIT MARGIN AVG 3Y
12.96%
NET PROFIT MARGIN AVG 5Y
8.08%
NET PROFIT MARGIN AVG 10Y
16.53%
NET PROFIT MARGIN AVG 15Y
16.21%
NET PROFIT MARGIN AVG 20Y
16.05%
CURRENT VS TTM AVG
-3.39%
CURRENT VS 3Y AVG
+41.61%
CURRENT VS 5Y AVG
+127.25%
CURRENT VS 10Y AVG
+11.10%
CURRENT VS 15Y AVG
+13.24%
CURRENT VS 20Y AVG
+14.42%
SECTOR MEDIAN · HEALTHCARE
8.68%
median of 98 covered companies
CURRENT VS SECTOR MEDIAN
+111.52%
vs the sector median at left
Illumina, Inc.
Market Cap
$41.31B
Net Profit Margin
18.36%
TTM Avg
19.00%
3Y Avg
12.96%
5Y Avg
8.08%
Market Cap
$40.89B
Net Profit Margin
25.03%
TTM Avg
23.70%
3Y Avg
22.66%
5Y Avg
22.55%
Market Cap
$41.75B
Net Profit Margin
3.58%
TTM Avg
20.93%
3Y Avg
21.85%
5Y Avg
22.39%
Market Cap
$42.50B
Net Profit Margin
8.10%
TTM Avg
8.63%
3Y Avg
8.47%
5Y Avg
7.22%
Market Cap
$46.04B
Net Profit Margin
4.08%
TTM Avg
-0.87%
3Y Avg
-5.42%
5Y Avg
-7.16%
Market Cap
$47.38B
Net Profit Margin
19.53%
TTM Avg
19.27%
3Y Avg
18.75%
5Y Avg
17.94%
Market Cap
$48.72B
Net Profit Margin
4.52%
TTM Avg
8.06%
3Y Avg
8.30%
5Y Avg
8.27%
Market Cap
$49.03B
Net Profit Margin
15.43%
TTM Avg
47.22%
3Y Avg
37.68%
5Y Avg
33.03%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Illumina, Inc. (ILMN) | $41.31B | 18.36% | 19.00% | 12.96% | 8.08% |
| IDEXX Laboratories, Inc. (IDXX)vs › | $40.89B | 25.03% | 23.70% | 22.66% | 22.55% |
| Waters Corporation (WAT)vs › | $41.75B | 3.58% | 20.93% | 21.85% | 22.39% |
| IQVIA Holdings Inc. (IQV)vs › | $42.50B | 8.10% | 8.63% | 8.47% | 7.22% |
| Teva Pharmaceutical Industries Limited (TEVA)vs › | $46.04B | 4.08% | -0.87% | -5.42% | -7.16% |
| Humana Inc. (HUM)vs › | $46.63B | 0.88% | 0.97% | 1.82% | 2.53% |
| Agilent Technologies, Inc. (A)vs › | $47.38B | 19.53% | 19.27% | 18.75% | 17.94% |
| Becton, Dickinson and Company (BDX)vs › | $48.72B | 4.52% | 8.06% | 8.30% | 8.27% |
| Edwards Lifesciences Corporation (EW)vs › | $49.03B | 15.43% | 47.22% | 37.68% | 33.03% |
| Biogen Inc. (BIIB)vs › | $32.49B | 8.39% | 15.03% | 17.95% | 19.29% |
Operating Margin
21.0%
Net Profit Margin
18.4%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-28 | 17.86% |
| 2026-03-29 | 12.28% |
| 2025-12-28 | 28.79% |
| 2025-09-28 | 13.85% |
| 2025-06-29 | 22.23% |
| 2025-03-30 | 12.58% |
| 2024-12-29 | 16.94% |
| 2024-09-29 | 65.28% |
| 2024-06-30 | -178.78% |
| 2024-03-31 | -11.71% |
| 2023-12-31 | -15.60% |
| 2023-10-01 | -67.38% |
| 2023-07-02 | -19.90% |
| 2023-04-02 | 0.28% |
| 2022-12-31 | -12.83% |
| 2022-10-02 | -342.24% |
| 2022-07-03 | -46.04% |
| 2022-04-03 | 7.03% |
| 2021-12-31 | 9.34% |
| 2021-10-03 | 28.61% |
| 2021-07-04 | 16.43% |
| 2021-04-04 | 13.45% |
| 2020-12-31 | 26.97% |
| 2020-09-27 | 22.54% |
| 2020-06-28 | 7.42% |
| 2020-03-29 | 20.14% |
| 2019-12-31 | 25.11% |
| 2019-09-29 | 25.80% |
| 2019-06-30 | 35.32% |
| 2019-03-31 | 27.54% |
| 2018-12-31 | 24.22% |
| 2018-09-30 | 23.33% |
| 2018-07-01 | 25.18% |
| 2018-04-01 | 26.60% |
| 2017-12-31 | 8.74% |
| 2017-10-01 | 22.83% |
| 2017-07-02 | 19.34% |
| 2017-04-02 | 62.37% |
| 2016-12-31 | 19.98% |
| 2016-10-02 | 21.23% |
| 2016-07-03 | 20.06% |
| 2016-04-03 | 15.67% |
| 2015-12-31 | 17.66% |
| 2015-09-27 | 21.48% |
| 2015-06-28 | 18.96% |
| 2015-03-29 | 25.37% |
| 2014-12-31 | 29.92% |
| 2014-09-28 | 19.45% |
| 2014-06-29 | 10.41% |
| 2014-03-30 | 14.25% |
| 2013-12-31 | 20.83% |
| 2013-09-29 | 8.79% |
| 2013-06-30 | 10.37% |
| 2013-03-31 | -6.82% |
| 2012-12-31 | 23.25% |
| 2012-09-30 | 10.41% |
| 2012-07-01 | 8.34% |
| 2012-04-01 | 9.61% |
| 2011-12-31 | 4.69% |
| 2011-10-02 | 8.56% |
| 2011-07-03 | 10.65% |
| 2011-04-03 | 8.54% |
| 2010-12-31 | 14.71% |
| 2010-10-03 | 14.94% |
| 2010-07-04 | 14.05% |
| 2010-04-04 | 11.04% |
| 2009-12-31 | 6.48% |
| 2009-09-27 | 10.78% |
| 2009-06-28 | 15.27% |
| 2009-03-29 | 11.35% |
| 2008-12-31 | 17.98% |
| 2008-09-28 | -4.85% |
| 2008-06-29 | 10.98% |
| 2008-03-30 | 11.02% |
| 2007-12-31 | -3.59% |
| 2007-09-30 | 14.87% |
| 2007-07-01 | 10.96% |
| 2007-04-01 | -413.13% |
| 2006-12-31 | 28.36% |
| 2006-10-01 | 30.23% |
| 2006-07-02 | 16.28% |
| 2006-04-02 | -0.36% |
| 2005-12-31 | 1.42% |
| 2005-10-02 | -7.31% |
| 2005-07-03 | -117.16% |
| 2005-04-03 | -8.15% |
| 2004-12-31 | 44.07% |
| 2004-10-03 | -14.99% |
| 2004-06-27 | -30.61% |
| 2004-03-28 | -39.89% |
| 2003-12-31 | -40.76% |
| 2003-09-28 | -66.81% |
| 2003-06-29 | -188.09% |
| 2003-03-30 | -218.38% |
| 2002-12-31 | -205.87% |
| 2002-09-29 | -254.67% |
